SCYNEXIS, Inc. (SCYX) Announces First Participants Dosed in Phase 1 Trial of SCY-247 Antifungal Therapy
On February 26, 2026, SCYNEXIS, Inc.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Squadron Capital Management William Blank | 951,086.875 | $6,976,412 | 2.56% | |
| 2. | Great Point Partners Jeffrey Jay And David Kroin | 944,293.375 | $6,926,581 | 1.59% | |
| 3. | Avidity Partners Management David Witzke And Michael Gregory | 260,207.5 | $1,908,674 | 0.37% | |
| 4. | Kingdon Capital Mark Kingdon | 247,811.375 | $1,817,746 | 0.2% | |
| 5. | DAFNA Capital Management Nathan Fischel | 135,869.5 | $996,630 | 0.23% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 108,695 | $0.00 | 1,357,126 | 2026-04-01 | Filing | |
| $1.37 | 20,000 | $27,400.00 | 507,871 | 2024-09-12 | Filing | |
| $3.00 | 75,000 | $225,000.00 | 272,068 | 2022-04-26 | Filing | |
| $3.00 | 3,500 | $10,500.00 | 53,499 | 2022-04-26 | Filing | |
| $6.25 | 8,000 | $50,000.00 | 8,000 | 2020-12-21 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.95 | 33,849 | $302,948.55 | 1,800,000 | 2021-01-22 | Filing | |
| $8.16 | 285,151 | $2,326,832.16 | 1,833,849 | 2021-01-22 | Filing | |
| $7.38 | 95,000 | $701,100.00 | 2,120,000 | 2021-01-21 | Filing | |
| $7.43 | 185,000 | $1,374,550.00 | 2,215,000 | 2021-01-20 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 260,870 | $1,913,534 | 0.53% | |
| 2. | 230,978.25 | $1,694,272 | 2.04% | |
| 3. | 195,549.75 | $1,434,553 | 0% | |
| 4. | 60,796 | $446,036 | 0% | |
| 5. | 41,524.25 | $304,589 | 0% |